creatine has been researched along with Weight Loss in 17 studies
Weight Loss: Decrease in existing BODY WEIGHT.
Excerpt | Relevance | Reference |
---|---|---|
"Multiple pilot studies, including one in colorectal cancer patients, suggest that creatine, an amino acid derivative, augments muscle, improves strength, and thereby could palliate the cancer anorexia/weight loss syndrome." | 9.24 | A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. ( Adonizio, CS; Atherton, PJ; Jaslowski, AJ; Jatoi, A; Le-Lindqwister, NA; Loprinzi, C; Moore, DF; Rowland, KM; Sloan, J; Steen, PD, 2017) |
"Multiple pilot studies, including one in colorectal cancer patients, suggest that creatine, an amino acid derivative, augments muscle, improves strength, and thereby could palliate the cancer anorexia/weight loss syndrome." | 5.24 | A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. ( Adonizio, CS; Atherton, PJ; Jaslowski, AJ; Jatoi, A; Le-Lindqwister, NA; Loprinzi, C; Moore, DF; Rowland, KM; Sloan, J; Steen, PD, 2017) |
"Weight loss is a common symptom of Parkinson's disease and is associated with impaired quality of life." | 2.84 | Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort. ( Boyd, J; Li, R; Pérez, A; Ren, X; Wills, AM, 2017) |
"Weight loss was 7." | 2.71 | Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. ( Clifton, PM; Foster, PR; Keogh, JB; Noakes, M, 2005) |
"Obesity is associated with adverse effects on brain health, including an increased risk of neurodegenerative diseases." | 1.91 | Change in medial frontal cerebral metabolite concentrations following bariatric surgery. ( Bottari, SA; Britton, MK; Chen, A; Cohen, RA; Friedman, J; Gunstad, J; Porges, EC; Williamson, JB; Woods, AJ, 2023) |
"Brain edema was maximal on MR imaging 3 h after poisoning." | 1.42 | Early brain magnetic resonance imaging can predict short and long-term outcomes after organophosphate poisoning in a rat model. ( Cohen, Y; Eisenkraft, A; Kadar, T; Kassirer, M; Milk, N; Rosman, Y; Shiyovich, A; Shrot, S; Tauber, M, 2015) |
"We report a case with morbid obesity whose renal function was stabilized with aggressive management of his obesity." | 1.33 | Does treating obesity stabilize chronic kidney disease? ( Agnani, S; Atray, NK; Gupta, R; Vachharajani, TJ; Vachharajani, VT, 2005) |
"Pulegone was given orally by gavage to groups of 28 SPF Wistar rats at dosage levels of 0 or 160 mg/kg body weight per day for 28 days." | 1.30 | Lack of histological cerebellar changes in Wistar rats given pulegone for 28 days. Comparison of immersion and perfusion tissue fixation. ( Mølck, AM; Olsen, P; Poulsen, M; Tindgard Lauridsen, S, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.88) | 18.7374 |
1990's | 3 (17.65) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
Bottari, SA | 1 |
Cohen, RA | 1 |
Friedman, J | 1 |
Porges, EC | 1 |
Chen, A | 1 |
Britton, MK | 1 |
Gunstad, J | 1 |
Woods, AJ | 1 |
Williamson, JB | 1 |
Schilling, E | 1 |
Böhmer, F | 1 |
Fritzsche, C | 1 |
Jatoi, A | 1 |
Steen, PD | 1 |
Atherton, PJ | 1 |
Moore, DF | 1 |
Rowland, KM | 1 |
Le-Lindqwister, NA | 1 |
Adonizio, CS | 1 |
Jaslowski, AJ | 1 |
Sloan, J | 1 |
Loprinzi, C | 1 |
Wills, AM | 1 |
Li, R | 1 |
Pérez, A | 1 |
Ren, X | 1 |
Boyd, J | 1 |
Genc, G | 1 |
Okuyucu, A | 1 |
Meydan, BC | 1 |
Yavuz, O | 1 |
Nisbet, O | 1 |
Hokelek, M | 1 |
Bedir, A | 1 |
Ozkaya, O | 1 |
Gungunes, A | 1 |
Ozbek, M | 1 |
Ginis, Z | 1 |
Sahin, M | 1 |
Demirci, T | 1 |
Cakir Ozkaya, E | 1 |
Karbek, B | 1 |
Sayki Arslan, M | 1 |
Ozturk Unsal, I | 1 |
Tutal Akkaya, E | 1 |
Ucan, B | 1 |
Gultuna Ozguclu, S | 1 |
Cakal, E | 1 |
Topaloglu, O | 1 |
Delibasi, T | 1 |
Shrot, S | 1 |
Tauber, M | 1 |
Shiyovich, A | 1 |
Milk, N | 1 |
Rosman, Y | 1 |
Eisenkraft, A | 1 |
Kadar, T | 1 |
Kassirer, M | 1 |
Cohen, Y | 1 |
Deldicque, L | 1 |
Francaux, M | 1 |
HUNTER, J | 1 |
RAULSTON, WR | 1 |
Noakes, M | 1 |
Keogh, JB | 1 |
Foster, PR | 1 |
Clifton, PM | 1 |
Agnani, S | 1 |
Vachharajani, VT | 1 |
Gupta, R | 1 |
Atray, NK | 1 |
Vachharajani, TJ | 1 |
Santos, RV | 1 |
Batista, ML | 1 |
Caperuto, EC | 1 |
Costa Rosa, LF | 1 |
Iwao, S | 1 |
Mori, K | 1 |
Sato, Y | 1 |
Mølck, AM | 1 |
Poulsen, M | 1 |
Tindgard Lauridsen, S | 1 |
Olsen, P | 1 |
Oöpik, V | 2 |
Pääsuke, M | 2 |
Timpmann, S | 2 |
Medijainen, L | 2 |
Ereline, J | 2 |
Smirnova, T | 1 |
Rockwell, JA | 1 |
Rankin, JW | 1 |
Toderico, B | 1 |
Gapejeva, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Multicenter, Double-Blind, Parallel Group, Placebo Controlled Study of Creatine in Subjects With Treated Parkinson's Disease (PD) Long Term Study (LS-1)[NCT00449865] | Phase 3 | 1,741 participants (Actual) | Interventional | 2007-03-31 | Terminated (stopped due to Futility) | ||
Food Allergen Eliminations and Combined Protocols for Obesity Reduction: a Preliminary Comparison Study[NCT03821818] | 20 participants (Anticipated) | Observational | 2018-03-05 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
All outcomes were coded such that higher scores indicated worse outcomes. Patients were ranked on each outcome and their ranks were summed (summed-ranks). Higher summed ranks (range, 5-4775) indicate worse outcomes. The mean summed ranks were compared by treatment group by a global statistical test (GST). (NCT00449865)
Timeframe: Change from baseline to 5 YEARS
Intervention | summed-ranks (Mean) |
---|---|
Placebo | 2360 |
Creatine | 2414 |
1 review available for creatine and Weight Loss
Article | Year |
---|---|
Potential harmful effects of dietary supplements in sports medicine.
Topics: Alkaloids; Amines; Creatine; Dietary Supplements; Drug Contamination; Drug Interactions; Drug Overdo | 2016 |
7 trials available for creatine and Weight Loss
Article | Year |
---|---|
A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial.
Topics: Aged; Anorexia; Creatine; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Placebo | 2017 |
Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort.
Topics: Age Factors; Antiparkinson Agents; Creatine; Disease Progression; Dopamine Agents; Double-Blind Meth | 2017 |
Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women.
Topics: Adipose Tissue; Adult; Biomarkers; Body Composition; Bone and Bones; Cardiovascular Diseases; Choles | 2005 |
Effects of meal frequency on body composition during weight control in boxers.
Topics: Adult; Body Composition; Body Mass Index; Body Weight; Boxing; Creatine; Diet, Reducing; Energy Meta | 1996 |
Effect of creatine supplementation during rapid body mass reduction on metabolism and isokinetic muscle performance capacity.
Topics: Adult; Ammonia; Biomechanical Phenomena; Creatine; Dietary Supplements; Glucose; Glycogen; Humans; L | 1998 |
Creatine supplementation affects muscle creatine during energy restriction.
Topics: Adipose Tissue; Adolescent; Adult; Body Composition; Creatine; Humans; Male; Muscle, Skeletal; Nitro | 2001 |
Effects of creatine supplementation during recovery from rapid body mass reduction on metabolism and muscle performance capacity in well-trained wrestlers.
Topics: Adult; Ammonia; Blood Glucose; Body Weight; Creatine; Cross-Over Studies; Dietary Supplements; Doubl | 2002 |
9 other studies available for creatine and Weight Loss
Article | Year |
---|---|
Change in medial frontal cerebral metabolite concentrations following bariatric surgery.
Topics: Bariatric Surgery; Choline; Creatine; Humans; Inositol; Obesity; Proton Magnetic Resonance Spectrosc | 2023 |
[20-year-old man with adynamia and syncopes].
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Animals; Creatine; Diagnosis, Differential; Huma | 2020 |
Effect of free creatine therapy on cisplatin-induced renal damage.
Topics: Animals; Antineoplastic Agents; Cisplatin; Creatine; DNA Damage; Drug Evaluation, Preclinical; Kidne | 2014 |
Serum nesfatin-1 levels in overt and subclinical hyperthyroidism.
Topics: Adult; Appetite; Blood Glucose; Body Mass Index; Body Weight; Calcium-Binding Proteins; Creatine; DN | 2014 |
Early brain magnetic resonance imaging can predict short and long-term outcomes after organophosphate poisoning in a rat model.
Topics: Animals; Aspartic Acid; Atropine; Behavior, Animal; Brain; Brain Edema; Choline; Cholinesterase Reac | 2015 |
Creatine concentration and weight loss in denervated skeletal muscle.
Topics: Creatine; Muscle, Skeletal; Muscles; Weight Loss | 1946 |
Does treating obesity stabilize chronic kidney disease?
Topics: Adult; Bariatric Surgery; Creatine; Gastric Bypass; Humans; Kidney; Kidney Failure, Chronic; Male; O | 2005 |
Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after Doxorubicin treatment in rats.
Topics: Alanine Transaminase; Animals; Antibiotics, Antineoplastic; Ascorbic Acid; Creatine; Creatinine; Dox | 2007 |
Lack of histological cerebellar changes in Wistar rats given pulegone for 28 days. Comparison of immersion and perfusion tissue fixation.
Topics: Animals; Cerebellum; Creatine; Cyclohexane Monoterpenes; Dose-Response Relationship, Drug; Female; L | 1998 |